Concepedia

Robert Gagnon

RG

32

Publications

3.5K

Citations

26

H-Index

1992

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

New Frontier

Bristol-Myers Squibb (United States)

Research Triangle Park Foundation

Memorial Sloan Kettering Cancer Center

Robert Gagnon is an author at GlaxoSmithKline (United States) specializing in medicine, immunology, and cancer research.

ORCID

Top concepts

Publications per year

1992–2023

32

Publications

32

Obstructive Lung Disease and Low Lung Function in Adults in the United States

David M. Mannino, Robert Gagnon, Thomas L. Petty et al. · Archives of Internal Medicine · 2000 · 713 citations

Concomitant cortical expression of TNF-α and IL-1β mRNAs follows early response gene expression in transient focal ischemia

Xinkang Wang, Tianli Yue, Frank C. Barone et al. · Molecular and Chemical Neuropathology · 1994 · 276 citations

, , +15

Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial

Toni K. Choueiri, David J. Figueroa, André P. Fay et al. · Clinical Cancer Research · 2014 · 242 citations · Full text

Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer

Manish A. Shah, Zev A. Wainberg, Daniel V.T. Catenacci et al. · PLoS ONE · 2013 · 204 citations · Full text

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis

Scott M. Palmer, Laurie D. Snyder, Jamie L. Todd et al. · CHEST Journal · 2018 · 202 citations · Full text

Rows per page

1–5 of 32